# Olpruva

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/olpruva
Canonical HTML page: https://getbiobrief.com/entity/olpruva

## Recent coverage (1 stories)

### Zevra Therapeutics Taps Biotech Veteran Justin Renz as New CFO
2026-03-05 13:45:59 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Zevra Therapeutics has appointed Justin Renz as its new Chief Financial Officer, bringing over 20 years of biotech leadership to the rare disease specialist. The move comes as Zevra prioritizes the commercial rollout of Miplyffa, its recently FDA-approved treatment for Niemann-Pick disease type C.
Full story: https://getbiobrief.com/story/zevra-therapeutics-appoints-justin-renz-cfo

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.